THE European Medicines Agency
has recommended the approval of
a new malaria treatment, Eurartesim.
The fixed combination drug
consists of dihydroartemisinin and
piperaquine phosphate and
intended for the treatment of
uncomplicated Plasmodium
falciparum malaria in adults,
children and infants aged 6 months
or over and weighing 5 kg or more.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jun 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jun 11
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.